MSMorando Soffritti

Morando Soffritti

*This is an algorithmically generated author record based on publicly available information.

Morando Soffritti has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Cesare Maltoni

    Cancer Research Center, European Ramazzini Foundation for Oncology and Environmental Sciences, Bologna, Italy

    6 shared publications
  • Fiorella Belpoggi

    Cancer Research Center, European Ramazzini Foundation for Oncology and Environmental Sciences, Bologna, Italy

    5 shared publications
  • Daniela Cevolani

    Cancer Research Center, European Ramazzini Foundation for Oncology and Environmental Sciences, Bologna, Italy

    2 shared publications
  • Franco Minardi

    2 shared publications
  • Luca Lambertini

    Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, USA

    2 shared publications
  • Marina Guarino

    Cancer Research Center, European Ramazzini Foundation for Oncology and Environmental Sciences, Bologna, Italy

    2 shared publications

Latest Publications

    • 1 December 2002
      • Vol. 982, 26-45

    Ramazzini Foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results.

    by Morando Soffritti, Fiorella Belpoggi, Franco Minardi, Cesare Maltoni

    The Ramazzini Foundation research program was started over thirty years ago. The features of this program are: (1) systematic and integrated project design; (2) consistency over time; (3) homogeneity of approach: key members of the team remain unchanged; and (4) choice to work on new frontiers of scientific research. The program centers mainly on three projects: Project 1: experimental carcinogenicity bioassays; Project 2: experimental anticarcinogenesis assays to identify factors and active principles (compounds) capable of opposing the onset of tumors while being suitable for preventive/chemopreventive intervention; Project 3: epidemiological studies, both descriptive and analytical, on tumor incidence and mortality in persons professionally and environmentally exposed to industrial carcinogenic risks. The project involving experimental carcinogenicity bioassays for the identification of exogenous carcinogens (environmental and industrial above all) began in 1966. This project has included 398 experimental bioassays on 200 compounds/agents using some 148,000 animals monitored until their spontaneous death. Among the studies already concluded, 47 agents have shown "clear evidence" of carcinogenicity. The results have demonstrated for the first time that (1) vinyl chloride can cause liver angiosarcoma as well as other tumors; (2) benzene is carcinogenic in experimental animals for various tissues and organs; (3) formaldehyde may produce lymphomas and leukemias; and (4) methyl-tert-butyl ether (MTBE), the most common oxygenated additive used in gasolines, can cause lymphomas/leukemias. Many of the results achieved have led to the introduction of norms and measures of primary prevention.


  • Results of Long‐Term Experimental Studies on the Carcinogenicity of Methyl Alcohol and Ethyl Alcohol in Rats

    by Morando Soffritti, Fiorella Belpoggi, Daniela Cevolani, Marina Guarino, Michela Padovani, Cesare Maltoni

    Abstract: Methyl alcohol was administered in drinking water supplied ad libitum at doses of 20,000, 5,000, 500, or 0 ppm to groups of male and female Sprague‐Dawley rats 8 weeks old at the start of the experiment. Animals were kept under observation until spontaneous death. Ethyl alcohol was administered by ingestion in drinking water at a concentration of 10% or 0% supplied ad libitum to groups of male and female Sprague‐Dawley rats; breeders and offspring were included in the experiment. Treatment started at 39 weeks of age (breeders), 7 days before mating, or from embryo life (offspring) and lasted until their spontaneous death. Under tested experimental conditions, methyl alcohol and ethyl alcohol were demonstrated to be carcinogenic for various organs and tissues. They must also be considered multipotential carcinogenic agents. In addition to causing other tumors, ethyl alcohol induced malignant tumors of the oral cavity, tongue, and lips. These sites have been shown to be target organs in man by epidemiologic studies.


  • Results of Long‐Term Experimental Studies on the Carcinogenicity of Formaldehyde and Acetaldehyde in Rats

    by Morando Soffritti, Fiorella Belpoggi, Luca Lambertin, Michelina Lauriola, Michela Padovani, Cesare Maltoni

    Abstract: Formaldehyde was administered for 104 weeks in drinking water supplied ad libitum at concentrations of 1500, 1000, 500, 100, 50, 10, or 0 mg/L to groups of 50 male and 50 female Sprague‐Dawley rats beginning at seven weeks of age. Control animals (100 males and 100 females) received tap water only. Acetaldehyde was administered to 50 male and 50 female Sprague‐Dawley rats beginning at six weeks of age at concentrations of 2,500, 1,500, 500, 250, 50, or 0 mg/L. Animals were kept under observation until spontaneous death. Formaldehyde and acetaldehyde were found to produce an increase in total malignant tumors in the treated groups and showed specific carcinogenic effects on various organs and tissues.


  • Results of Long‐Term Experimental Studies on the Carcinogenicity of Ethylene‐bis‐Dithiocarbamate (Mancozeb) in Rats

    by Fiorella Belpoggi, Morando Soffritti, Marina Guarino, Luca Lambertini, Daniela Cevolani, Cesare Maltoni

    Abstract: Mancozeb, an ethylene‐bis‐dithiocarbamate (EBDC), has been one of the most commonly used fungicides in commercial use for several decades. Nevertheless, up to now, no adequate published experimental studies on the carcinogenicity of Mancozeb have been published. Because of the importance of the compound and of the number of people potentially exposed (workers engaged in the production and use of the fungicide, people living in agricultural areas where the compound is sprayed, and people consuming polluted products), a long‐term experimental study of Mancozeb was begun at the Cancer Research Center of the Ramazzini Foundation. Groups of 150 male and female Sprague‐Dawley rats, 8 weeks old at the start of the treatment, were administered Mancozeb at the concentration of 1000, 500, 100, 10, and 0 ppm in feed supplied ad libitum for 104 weeks. At the end of the treatment, animals were kept under controlled conditions until spontaneous death. Mancozeb caused an increase in (1) total malignant tumors, (2) malignant mammary tumors, (3) Zymbal gland and ear duct carcinomas, (4) hepatocarcinomas, (5) malignant tumors of the pancreas, (6) malignant tumors of the thyroid gland, (7) osteosarcomas of the bones of the head, and (8) hemolymphoreticular neoplasias. On the basis of these data, Mancozeb must be considered a multipotent carcinogenic agent.


  • The Scientific and Methodological Bases of Experimental Studies for Detecting and Quantifying Carcinogenic Risks

    by Cesare Maltoni, Morando Soffritti, Fiorella Belpoggi

    Abstract: This paper outlines the aims and potential scope of experimental research for risk identification and assessment in industrial carcinogenesis (environmental and occupational). It then reviews the basic, general, and specific requisites of a rigorously scientific nature that are required to render experiments to be more appropriate and better geared to the information they seek. A range of experimental approaches to risk assessment are illustrated by results achieved in the Cancer Research Centre of the Ramazzini Foundation (CRC/RF). The paper ends with a call for closer relations and integration among experimental, epidemiologic, and biostatistical studies.


  • Mega‐experiments to Identify and Assess Diffuse Carcinogenic Risks

    by Morando Soffritti, Fiorella Belpoggi, Franco Minardi, Luciano Bua, Cesare Maltoni

    Diffuse carcinogenic risks, that is, those of low potency involving large areas of population and sometimes all mankind, pose a serious public health problem. Controlling these risks might help to reduce the incidence of, and mortality from, cancer. Because of their low expected carcinogenic potential, these risks are difficult to expose or assess. Epidemiologic investigation is of limited use in this field and yields its data too late to be useful. Experimental studies offer the only possible approach for assessing such risks. To increase experimental sensitivity and consistency of results, mega‐experiments must be designed. That is, experiments that use a large number of animals with a well‐known basic tumorigram, that extend the exposure and the biophase for as long as possible, that carefully observe the effects, and that are performed with suitable standardized methods. In the last 15 years the Ramazzini Foundation, in its Cancer Research Center at Bentivoglio, has conducted or planned five mega‐experiments. Initial results indicate the great potential of these methods for identifying and assessing diffuse risks.